TONAWANDA, N.Y. — Martin Kober is convinced the painting of a dying Jesus that hung above the mantel in his upstate New York childhood home is the work of Michelangelo. Getting experts to agree remains the $300 million hurdle. That’s the potential value of the 19-by-25-inch work that Kober’s family affectionately calls the “the Mike,”...
NYS Entity Status
NYS Filing Date
APRIL 25, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - NORTHERN GREEN LANDSCAPING & PLOWING INC.
AROUND THE WEB
- Man convinced living room painting is $300M Michelangelo masterpiece
By Associated Press - Thursday Jul 20, 2017
- The South Park Commons Fills a Hole in the Tech Landscape
By CADE METZ - Sunday Jul 2, 2017
The Bay Area tech scene has start-up incubators and hacker spaces. But what do you do when you want to figure out your next move?
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Northern Star Fire’s E-compass Wins Governor’s Business Plan Contest
By Jeff Buchanan - Thursday Jun 8, 2017
According to the U.S. Fire Administration, 1,002 firefighters died while on duty between 2006 and 2015. Jeff Dykes, a fire captain and entrepreneur, believes some of those fatalities could have been avoided if the firefighters had been able to determine what direction they were facing while inside of burning buildings. Dykes is the founder of Eau Claire, […]
- CRISPR Pioneer Jennifer Doudna On Gene Editing’s Potential For Good And Evil
By Noah Robischon - Tuesday Jun 20, 2017
CRISPR coinventor Jennifer Doudna talks about developing the gene-editing tool that’s poised to change the world.
Scientists now have a relatively easy and inexpensive way to read, write, and edit the building blocks of life—the genome-editing technique known as CRISPR-Cas9. And while the technology was developed only five years ago, CRISPR’s ability to target—and modify—specific sections of DNA is already supercharging the pace of scientific breakthroughs in medicine and agriculture. It’s even being used to try to bring the woolly mammoth back to life. Investors (including Bill Gates and Sean Parker) and pharmaceutical companies have plowed millions of dollars into CRISPR-driven research; philanthropies have granted millions more to support scientists working on cures for genetic diseases; and in China, at least seven human clinical trials are moving forward. But it all started when a small group of scientists, working in collaboration, stumbled on an organic biological process that had existed for millennia. Among the leaders was molecular biologist Jennifer Doudna, who heads the Doudna Lab at the University of California, Berkeley. She’s the coauthor of a new book tracing CRISPR’s evolution, A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. “[CRISPR] is a great illustration of how technologies are born,” says Doudna. “They often come about in unexpected ways.” And the outcomes can be just as unpredictable, and dangerous—a fact that has prompted her to become a global advocate for the responsible use of CRISPR. In this excerpt, Doudna talks about its transformative power. —Noah Robischon
- Arzeda Raises $12M for Computational Protein Design
By Benjamin Romano - Thursday Jul 20, 2017
Nine years passed between Arzeda’s emergence from the Baker lab at University of Washington and the $12 million Series A funding round the Seattle computational protein design company announced Thursday. But Arzeda has grown the old-fashioned way: by bringing in revenue from customers, and plowing profits back into the company. The company has developed custom […]